Effects of sibutramine in non-dieting obese women

Journal of Endocrinological Investigation

Volumn 25, Issue 2, 2002, Pages 101-105

  Gokcel, Adnan ^a   Gumurdulu, Y ^a   Karakose, H ^a   Karademir, B M ^a   Anarat, R ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

Insulin resistance; Leptin; Obesity; Sibutramine; Weight loss

Indexed keywords

C PEPTIDE; GLUCOSE; INSULIN; LEPTIN; PLACEBO; SIBUTRAMINE;

AGED; AREA UNDER THE CURVE; ARTICLE; BODY COMPOSITION; BODY FAT; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; DIETARY INTAKE; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HOMEOSTASIS; HORMONE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PROTEIN BLOOD LEVEL; STATISTICAL SIGNIFICANCE; WEIGHT REDUCTION;

ADULT; APPETITE DEPRESSANTS; BLOOD GLUCOSE; BODY MASS INDEX; C-PEPTIDE; CYCLOBUTANES; FEMALE; GLUCOSE TOLERANCE TEST; HOMEOSTASIS; HUMANS; INSULIN; INSULIN RESISTANCE; LEPTIN; LIVER; OBESITY; PLACEBOS;

EID: 0036119916     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03343971     Document Type: Article

References (29)

1. National Institute of Health Consensus Development Conference Statement. Health Implications of Obesity
2. Obesity: Take it seriously, deal with it now
3. World Health Organization warns of growing "crisis of suffering"
4. Sibutramine and energy balance
5. Obesity - A modern-day epidemic: Metabolic abnormalities and the role of leptin in human obesity
6. Anti-obesity drugs: What does sibutramine offer? An analysis of its potential contribution to obesity treatment
7. Obesity and the hypothalamus; Novel peptides for new pathways
8. Leptin and the hypothalamus: Neuroendocrine control of food intake
9. Obesity results as a consequence of glucocorticoid induced leptin resistance
10. Decreased plasma leptin levels in lean and obese Zucker rats after treatment with the serotonin reuptake inhibitor fluoxetine
11. Insulin sensitivity indices obtained from oral glucose tolerance testing: Comparison with the euglycemic insulin clamp
12. A mathematical model for the determination of total area under glucose tolerance and other metabolic curves
13. Serotonin (5-hydroxytryptamine), a novel regulator of glucose transport in rat skeletal muscle
14. Effect of sibutramine on weight maintenance after weight loss: A randomised trial
15. Studies on the role of serotonin receptor subtypes in the effect of sibutramine in various feeding paradigm in rats
16. Sibutramine reduces food intake in non-dieting women with obesity
17. Effects of the obese gene product on body weight regulation in ob/ob mice
18. Weight-reducing effects of the plasma protein encoded by the obese gene
19. Recombinant mouse OB protein: Evidence for a peripheral signal linking adiposity to central neural networks
20. Effects of intravenously infused leptin on insulin sensitivity and on expression of uncoupling proteins in brown adipose tissue
21. Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects
22. Serum immunoreactive-leptin concentrations in normal-weight and obese humans
23. Overexpression of the obese (ob) gene in adipose tissue of human obese subjects
24. Relationship between circulating leptin and peripheral fat distribution in obese subjects
25. Effect of fasting on serum leptin in normal human subjects
26. Activation of beta (3) adrenergic receptors suppresses leptin expression and mediates a leptin-independent inhibition of food intake in mice
27. Beta-3 adrenergic-mediated suppression of leptin gene expression in rats
28. Effects of fasting and glucose infusion on basal and overnight leptin concentrations in normal-weight women
29. Sibutramine: A serotonin-norepinephrine reuptake-inhibitor for the treatment of obesity